Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study.

Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study.

التفاصيل البيبلوغرافية
المؤلف الرئيسي: Matthews, DR
التنسيق: Journal article
اللغة:English
منشور في: 2011

مواد مشابهة